Fundraising Fox
PreComb
Founded 2018 · 12 employees on LinkedIn · 2 known investors
Find your way into PreComb
Sign up to see every warm intro you have to PreComb
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PreComb team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.
Investors · 2
Frequently asked questions
- What does PreComb do?
- PreComb is a Swiss biotech company developing its proprietary 3DTwin technology, which combines automated drug testing on patient-derived tumor twins with AI-guided data analysis and response prediction. The technology is designed for use in the clinic to support evidence-based, personalized treatment decisions in oncology.
- Who are PreComb's investors?
- PreComb's investors include LongeVC, Kinled Holding.